Lv4
634 积分 2024-06-03 加入
Combined KRAS Inhibition and Immune Therapy Generates Durable Complete Responses in an Autochthonous PDAC Model
5天前
已完结
RIG-I activation is critical for responsiveness to checkpoint blockade
6天前
已完结
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
6天前
已完结
Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort
6天前
已完结
Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)
6天前
已完结
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma
6天前
已完结
MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer
17天前
已完结
Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe
17天前
已完结
RIG-I activation is critical for responsiveness to checkpoint blockade
17天前
已完结
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
17天前
已完结
皖公网安备34019202002308
